Commonwealth Equity Services, LLC Infla Rx N.V. Transaction History
Commonwealth Equity Services, LLC
- $66 Billion
- Q3 2024
A detailed history of Commonwealth Equity Services, LLC transactions in Infla Rx N.V. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 92,500 shares of IFRX stock, worth $202,575. This represents 0.0% of its overall portfolio holdings.
Number of Shares
92,500
Previous 102,500
9.76%
Holding current value
$202,575
Previous $178,000
20.22%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding IFRX
# of Institutions
29Shares Held
12.9MCall Options Held
19.3KPut Options Held
0-
Suvretta Capital Management, LLC New York, NY5.73MShares$12.6 Million0.35% of portfolio
-
683 Capital Management, LLC New York, NY2.07MShares$4.53 Million0.29% of portfolio
-
Eversept Partners, LP New York, NY1.62MShares$3.55 Million0.2% of portfolio
-
Ubs Oconnor LLC Chicago, IL798KShares$1.75 Million0.08% of portfolio
-
Ikarian Capital, LLC Dallas, TX705KShares$1.54 Million0.19% of portfolio
About InflaRx N.V.
- Ticker IFRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,203,800
- Market Cap $96.8M
- Description
- InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...